EverPoint Asset Management’s Medicines Co MDCO Stock Holding History

EverPoint Asset Management’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-700,000	Closed	-$26.4M	–	580
2016 Q3	$26.4M	Buy	700,000 +164,385	+31%	+$6.2M	0.48%	52
2016 Q2	$18M	Sell	535,615 -84,385	-14%	-$2.98M	0.36%	80
2016 Q1	$19.7M	Buy	620,000 +270,000	+77%	+$8.82M	0.39%	58
2015 Q4	$13.1M	Buy	+350,000	New	+$13.2M	0.27%	115
2015 Q2	–	Sell	-675,000	Closed	-$18.9M	–	641
2015 Q1	$18.9M	Buy	675,000 +475,000	+238%	+$13.3M	0.36%	77
2014 Q4	$5.53M	Buy	+200,000	New	+$4.96M	0.12%	239

Other funds holding MDCO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

EverPoint Asset Management's MDCO Position: Q4 2016 in Review

EverPoint Asset Management sold out of Medicines Co (MDCO) in Q4 2016, closing a stake of 700,000 shares — an estimated $26.4M sold.

EverPoint Asset Management first reported a position in MDCO in Q4 2014 and held it in 6 quarters. The position peaked at $26.4M in Q3 2016. 195 funds tracked by Wall St. Rank hold MDCO as of Q4 2016.

EverPoint Asset Management reported no remaining Medicines Co position as of Q4 2016 after selling out during the quarter.
EverPoint Asset Management sold 700,000 Medicines Co shares in Q4 2016, an estimated $26.4M.
EverPoint Asset Management first reported a position in Medicines Co in Q4 2014 and held it in 6 quarters.
EverPoint Asset Management's Medicines Co position peaked at $26.4M in Q3 2016.
195 funds tracked by Wall St. Rank held Medicines Co as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.